Cite
APA Citation
Stewart, J., Strickler, J., Mettu, N., MacLaughlan, S., Niedzwiecki, D., Levine, E., & Blazer, D. (n.d.). 409 A phase i trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO). Journal for immunotherapy of cancer, 8, A434. http://access.bl.uk/ark:/81055/vdc_100144718941.0x000004